New neuroprotective genes against axonal damage and glaucoma
Description: Loss of vision in glaucoma is caused by injury and death of the cells that connect the eye to the brain. Current treatments can delay the progression of cell death and vision loss, but no treatment exists to rescue injured cells and regenerate lost connections. Mammalian models of glaucoma also demonstrate this susceptibility to cellular injury and death without successful regeneration. In contrast, the zebrafish model exhibits resilience to injury and successful regeneration of lost connections to recover vision. Our laboratory is comparing the molecular and genetic response of zebrafish to mammals under conditions that model glaucoma. We have identified zebrafish-specific genes and responses that might mediate this difference. The current project uses loss of function studies in zebrafish and gain of function studies in mammalian cells to test the neuroprotective ability of four candidate genes identified in zebrafish. We will also generate the tools to test the function of these genes in mammalian models of optic nerve injury and glaucoma in vivo. The goal of this study is to understand the basic biology of injury resilience and optic nerve regeneration in the zebrafish and apply that knowledge to mammalian models of glaucoma with the long-term hopes of identifying new avenues for therapeutic development in patients.
Funder: BrightFocus Foundation
Amount: $200,000
Funding type: research
Funder scheme: National Glaucoma Research: Standard
Start date: 2021-07-01
End date: 2023-06-30
Investigator: Matthew Veldman (lead)
Institution: Medical College of Wisconsin
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Funded outputs count: 0
Funder award ID: G2021015S
OpenAlex ID: G9000672064
